| Ameloot, Koen |
3DCT-RCA, NCT05172323: Pre-procedural 3DCT Versus Angiography Guided PCI for Ostial Right Coronary Artery Lesions |
|
|
| Completed | N/A | 30 | Europe | 3DCT-scan, Angiography guided PCI | Ziekenhuis Oost-Limburg | Coronary Artery Disease | 02/23 | 02/23 | | |
| Verhaert, David |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
REMOTE, NCT05006105: Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients |
|
|
| Recruiting | N/A | 225 | Europe | seven-day ECG Holter, 24-hour blood pressure monitor, Questionnaire: vision of mHealth, Questionnaire: user experience & feeling of safety, Insertable loop recorder | Ziekenhuis Oost-Limburg, Hasselt University, Jessa Hospital | Cryptogenic Stroke, Atrial Fibrillation | 02/25 | 02/25 | | |
| Ferdinande, Bert |
COL BE PCI, NCT06095765: Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention |
|
|
| Recruiting | 3 | 2770 | Europe | Colchicine 0.5 MG Oral Tablet, Placebo | AZ Sint-Jan AV, University Hospital, Ghent, Belgium Health Care Knowledge Centre | Coronary Artery Disease | 11/27 | 03/28 | | |
PINNACLE I, NCT05828173: A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter |
|
|
| Active, not recruiting | N/A | 60 | Europe | LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter (LithiX Coronary HCIVLC; LithiX) | Elixir Medical Corporation | Coronary Artery Disease | 04/24 | 09/24 | | |
| Recruiting | N/A | 500 | Europe | RAP TAVI | AZ Sint-Jan AV | Aortic Valve Stenosis | 06/24 | 06/24 | | |
